BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9788237)

  • 1. Characterizations of Pneumocystis carinii and rat lung lipids: glyceryl ethers and fatty alcohols.
    Kaneshiro ES; Guo Z; Sul D; Kallam KA; Jayasimhulu K; Beach DH
    J Lipid Res; 1998 Oct; 39(10):1907-17. PubMed ID: 9788237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glyceryl ethers of Paramecium phospholipids and phosphonolipids.
    Kaneshiro ES; Meyer KB; Rhoads DE
    J Protozool; 1987 Nov; 34(4):357-61. PubMed ID: 3430407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acid composition of the major phospholipids of Pneumocystic carinii: comparison with those in the lungs of normal and methylprednisolone-immunosuppressed rats.
    Guo Z; Beach DH; Kaneshiro ES
    Infect Immun; 1996 Apr; 64(4):1407-12. PubMed ID: 8606108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of alkyl glyceryl ethers in the rat.
    Oswald EO; Anderson CE; Piantadosi C; Lim J
    Lipids; 1968 Jan; 3(1):51-8. PubMed ID: 17805842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.
    Guo Z; Kaneshiro ES
    Infect Immun; 1995 Apr; 63(4):1286-90. PubMed ID: 7890386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of alpha-glyceryl ethers by Crithidia fasciculata. I. Study of the in vivo degradation of exogenous chimyl and batyl alcohols.
    Gabrielides C; Kapoulas VM
    J Protozool; 1981 Nov; 28(4):441-7. PubMed ID: 7320947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of glyceryl ethers in the phosphatidylcholine fraction of surfactant from dog lungs.
    Kumar R; King RJ; Hanahan DJ
    Biochim Biophys Acta; 1985 Aug; 836(1):19-26. PubMed ID: 3839684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detailed analyses of individual neutral lipid classes of Pneumocystis.
    Kallam KA; Kaneshiro ES
    J Eukaryot Microbiol; 1996; 43(5):51S. PubMed ID: 8822853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of alk-1-enyl- and alkyl-glyceryl ethers in neutral lipids and phospholipids.
    Wood R; Snyder F
    Lipids; 1968 Mar; 3(2):129-35. PubMed ID: 17805900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Composition of Pneumocystis carinii neutral lipids and identification of coenzyme Q10 as the major ubiquinone homolog.
    Ellis JE; Wyder MA; Zhou L; Gupta A; Rudney H; Kaneshiro ES
    J Eukaryot Microbiol; 1996; 43(3):165-70. PubMed ID: 8640186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizations of neutral lipid fatty acids and cis-9,10-epoxy octadecanoic acid in Pneumocystis carinii carinii.
    Kaneshiro ES; Ellis JE; Guo Z; Jayasimhulu K; Maiorano JN; Kallam KA
    Infect Immun; 1996 Oct; 64(10):4105-14. PubMed ID: 8926076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.
    Mueller HW; O'Flaherty JT; Greene DG; Samuel MP; Wykle RL
    J Lipid Res; 1984 Apr; 25(4):383-8. PubMed ID: 6427378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ether-linked lipids of Balb/c3T3, SV3T3 and concanavalin A-selected SV3T3 revertant cells.
    Fallani A; Bracco M; Tombaccini D; Mugnai G; Ruggieri S
    Biochim Biophys Acta; 1982 May; 711(2):208-12. PubMed ID: 6284240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ether phospholipids in control and 20:4-depleted rat PMN: additional evidence for a 1-O-alkyl-2-20:4-sn-glycerol-3-phosphocholine specific phospholipase A2.
    Pickett WC; Ramesha CS
    Agents Actions; 1987 Aug; 21(3-4):390-2. PubMed ID: 3120515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
    Triggiani M; Connell TR; Chilton FH
    J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ether-linked lysophospholipids initiate insulin secretion. Lysophospholipids may mediate effects of phospholipase A2 activation on hormone release.
    Metz SA
    Diabetes; 1986 Jul; 35(7):808-17. PubMed ID: 3087803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for different mechanisms involved in the formation of lyso platelet-activating factor and the calcium-dependent release of arachidonic acid from human neutrophils.
    Winkler JD; Sung CM; Hubbard WC; Chilton FH
    Biochem Pharmacol; 1992 Nov; 44(10):2055-66. PubMed ID: 1449523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of temperature on glyceryl ethers in Tetrahymena pyriformis W.
    Lund-Katz S; Conner RL
    J Lipid Res; 1982 Dec; 23(9):1301-7. PubMed ID: 6819334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary ether lipid incorporation into tissue plasmalogens of humans and rodents.
    Das AK; Holmes RD; Wilson GN; Hajra AK
    Lipids; 1992 Jun; 27(6):401-5. PubMed ID: 1630273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.